International Biotechnology (LON:IBT) Share Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened

International Biotechnology (LON:IBTGet Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 680.90 ($8.57) and traded as low as GBX 674 ($8.48). International Biotechnology shares last traded at GBX 680 ($8.56), with a volume of 39,054 shares changing hands.

International Biotechnology Trading Down 0.6 %

The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32. The company has a market capitalization of £251.33 million, a price-to-earnings ratio of 1,416.67 and a beta of 0.21. The business has a fifty day moving average price of GBX 694.15 and a 200 day moving average price of GBX 680.90.

International Biotechnology Increases Dividend

The company also recently declared a dividend, which will be paid on Friday, January 24th. Stockholders of record on Thursday, December 19th will be issued a GBX 15.56 ($0.20) dividend. This is a positive change from International Biotechnology’s previous dividend of $14.50. The ex-dividend date is Thursday, December 19th. This represents a dividend yield of 2.21%. International Biotechnology’s payout ratio is 6,041.67%.

Insider Activity at International Biotechnology

In other International Biotechnology news, insider Katherine Cornish-Bowden acquired 1,500 shares of the business’s stock in a transaction dated Tuesday, December 17th. The shares were acquired at an average price of GBX 713 ($8.97) per share, for a total transaction of £10,695 ($13,457.91). 4.18% of the stock is owned by corporate insiders.

About International Biotechnology

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Read More

Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.